Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 519

2.

Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.

Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.

Arthritis Rheum. 2005 Mar;52(3):759-69.

3.

PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in naïve, untreated cells and enhancement in LPS-stimulated cells.

Sergeeva MG, Aleshin SE, Grabeklis S, Reiser G.

J Neurochem. 2010 Oct;115(2):399-410. doi: 10.1111/j.1471-4159.2010.06931.x. Epub 2010 Aug 25.

4.

Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.

Röhrl C, Kaindl U, Koneczny I, Hudec X, Baron DM, König JS, Marian B.

J Cancer Res Clin Oncol. 2011 Jan;137(1):29-39. doi: 10.1007/s00432-010-0856-1. Epub 2010 Mar 11.

PMID:
20221637
5.
6.

Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.

Chistyakov DV, Aleshin SE, Astakhova AA, Sergeeva MG, Reiser G.

J Neurochem. 2015 Jul;134(1):113-24. doi: 10.1111/jnc.13101. Epub 2015 Apr 16.

7.

Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.

Aleshin S, Strokin M, Sergeeva M, Reiser G.

Neurochem Int. 2013 Oct;63(4):322-30. doi: 10.1016/j.neuint.2013.06.012. Epub 2013 Jun 25. Review.

PMID:
23811400
8.
10.

Peroxisome-proliferator-activated receptors and the control of levels of prostaglandin-endoperoxide synthase 2 by arachidonic acid in the bovine uterus.

Sheldrick EL, Derecka K, Marshall E, Chin EC, Hodges L, Wathes DC, Abayasekara DR, Flint AP.

Biochem J. 2007 Aug 15;406(1):175-83.

11.
12.

A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.

Leisewitz AV, Urrutia CR, Martinez GR, Loyola G, Bronfman M.

J Cell Physiol. 2008 Nov;217(2):367-76. doi: 10.1002/jcp.21509.

PMID:
18543250
13.

Regulation of peroxisome proliferator-activated receptor β/δ expression and activity levels by toll-like receptor agonists and MAP kinase inhibitors in rat astrocytes.

Chistyakov DV, Aleshin S, Sergeeva MG, Reiser G.

J Neurochem. 2014 Aug;130(4):563-74. doi: 10.1111/jnc.12757. Epub 2014 May 28.

14.
15.

Mono(2-ethylhexyl)phthalate and mono-n-butyl phthalate activation of peroxisome proliferator activated-receptors alpha and gamma in breast.

Venkata NG, Robinson JA, Cabot PJ, Davis B, Monteith GR, Roberts-Thomson SJ.

Toxicol Lett. 2006 Jun 1;163(3):224-34. Epub 2005 Dec 1.

PMID:
16326050
16.

Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.

Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, Valledor AF, Davis RA, Willson TM, Witztum JL, Palinski W, Glass CK.

J Clin Invest. 2004 Dec;114(11):1564-76.

17.

Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.

Gilde AJ, van der Lee KA, Willemsen PH, Chinetti G, van der Leij FR, van der Vusse GJ, Staels B, van Bilsen M.

Circ Res. 2003 Mar 21;92(5):518-24. Epub 2003 Feb 6.

18.

Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.

Taketa K, Matsumura T, Yano M, Ishii N, Senokuchi T, Motoshima H, Murata Y, Kim-Mitsuyama S, Kawada T, Itabe H, Takeya M, Nishikawa T, Tsuruzoe K, Araki E.

J Biol Chem. 2008 Apr 11;283(15):9852-62. doi: 10.1074/jbc.M703318200. Epub 2008 Jan 21.

19.

Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.

Borland MG, Khozoie C, Albrecht PP, Zhu B, Lee C, Lahoti TS, Gonzalez FJ, Peters JM.

Cell Signal. 2011 Dec;23(12):2039-50. doi: 10.1016/j.cellsig.2011.07.020. Epub 2011 Aug 4.

20.

Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.

Palkar PS, Borland MG, Naruhn S, Ferry CH, Lee C, Sk UH, Sharma AK, Amin S, Murray IA, Anderson CR, Perdew GH, Gonzalez FJ, Müller R, Peters JM.

Mol Pharmacol. 2010 Sep;78(3):419-30. doi: 10.1124/mol.110.065508. Epub 2010 Jun 1.

Supplemental Content

Support Center